Published by
@ShahidNShah
@ShahidNShah
March 25 to March 27, 2024
The Colonnade, 120 Huntington Ave, Boston, Massachusetts, 02116, United States
The dynamic field of neuroimmunology has made significant progress, particularly in the investigation of targets such as TREM2, RIPK1, ferroptosis, NLRP3, LRRK2, and beyond. However, translating these discoveries into clinical success remains a challenge in neurology. To address the unmet patient needs in conditions like Alzheimer's, Parkinson's, and multiple sclerosis, understanding and leveraging microglia, astrocytes, oligodendrocytes, and adaptive immune cells is crucial. This event brings together 100+ experts from biopharma organizations to explore glial biology, neuroinflammatory targets, immune contributions, cutting-edge models, biomarkers, and clinical insights, with the goal of advancing transformative therapeutics for neurological disorders.
Read on neuroimmunology-drugdevelopment.com
Continue reading at neuroimmunology-drugdevelopment.com
March 25 to March 27, 2024
Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm